Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.7B | 19.7B | 17.2B | 16.9B |
Cost of revenue | 11.7B | 10.3B | 8.4B | 8.7B |
Gross profit | 10.0B | 9.4B | 8.7B | 8.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.9B | 2.7B | 2.8B | 2.4B |
Operating income | 4.9B | 4.8B | 4.0B | 4.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 287.8M | 305.1M | 297.4M | 274.7M |
Other income expense | — | — | — | — |
Pretax income | 4.6B | 4.6B | 4.1B | 4.1B |
Tax provision | 1.2B | 1.2B | 1.0B | 1.1B |
Net income | 3.5B | 3.4B | 3.0B | 3.0B |
Basic EPS | — | 34.8 | 31.6 | 31.7 |
Diluted EPS | — | 34.8 | 31.6 | 31.7 |
Basic average shares | — | 90.5M | 90.5M | 90.5M |
Diluted average shares | — | 90.5M | 90.5M | 90.5M |
EBITDA | 5.4B | 5.4B | 4.8B | 4.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | -238.8M | -226.3M | -179M | -140.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |